MedTrace Logo

SelectSecure 3830 Lead Imaging

NCT03941275 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 51

Last updated 2022-03-15

No results posted yet for this study

Summary

This study is designed to collect high-quality shoulder and intracardiac bi-plane fluoroscopic images during two standard arm motions on patients implanted with a market released SelectSecure 3830 lead for the purposes of developing a fracture reliability model.

Conditions

  • Heart Diseases

Interventions

DIAGNOSTIC_TEST

Bi-plane fluoroscopy

In vivo acquisition of biplane cine radiographic images of the market released Medtronic SelectSecure 3830 pacing lead

Sponsors & Collaborators

  • Medtronic Cardiac Rhythm and Heart Failure

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-24
Primary Completion
2020-11-03
Completion
2021-11-15
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03941275 on ClinicalTrials.gov